drug

oveporexton

1 story · latest Aug 5, 2026

Status: FDA approved Aug 2026 · NDA220860
Brand: Orzeyful

Relationships

Developed by Takeda Pharmaceutical Co Ltd

Timeline

FDA approves Takeda's Orzeyful for new molecular entity application

Aug 5Regulatory decisionoveporexton Takeda Pharmaceutical Co Ltd

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.